Calvin R. Jerde

490 total citations
13 papers, 329 citations indexed

About

Calvin R. Jerde is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Calvin R. Jerde has authored 13 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Infectious Diseases. Recurrent topics in Calvin R. Jerde's work include Pancreatic and Hepatic Oncology Research (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Epigenetics and DNA Methylation (3 papers). Calvin R. Jerde is often cited by papers focused on Pancreatic and Hepatic Oncology Research (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Epigenetics and DNA Methylation (3 papers). Calvin R. Jerde collaborates with scholars based in United States, Egypt and India. Calvin R. Jerde's co-authors include Robert B. Diasio, Steven M. Offer, Shikshya Shrestha, Gabriel L. Butterfield, Natalie J. Wegner, Croix C. Fossum, Hu Li, Cheng Zhang, Pawan K. Vohra and Venkatachalem Sathish and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Journal of Clinical Microbiology.

In The Last Decade

Calvin R. Jerde

12 papers receiving 325 citations

Peers

Countries citing papers authored by Calvin R. Jerde

Since Specialization

Citations

This map shows the geographic impact of Calvin R. Jerde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Calvin R. Jerde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Calvin R. Jerde more than expected).

Fields of papers citing papers by Calvin R. Jerde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Calvin R. Jerde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Calvin R. Jerde. The network helps show where Calvin R. Jerde may publish in the future.

Co-authorship network of co-authors of Calvin R. Jerde

This figure shows the co-authorship network connecting the top 25 collaborators of Calvin R. Jerde. A scholar is included among the top collaborators of Calvin R. Jerde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Calvin R. Jerde. Calvin R. Jerde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	A supervised learning method for classifying methylation disorders 2024 ·BMC Bioinformatics ·Jesse R. Walsh, Guangchao Sun, (unknown), Jayson Hardcastle, (unknown), Calvin R. Jerde, Kandelaria M. Rumilla, (unknown), (unknown), Linda Hasadsri, Benjamin R. Kipp, Garrett Jenkinson, Eric W. Klee	1
2	Evaluating User Experience and DNA Yield from Self-Collection Devices 2024 ·The Journal of Applied Laboratory Medicine ·Joseph H. Blommel, Matthew M. Roforth, Calvin R. Jerde, (unknown), (unknown), Jesse S. Voss, Luigi Boccuto, (unknown), Sara M. Sarasua, Benjamin R. Kipp, Stephen J. Murphy	0
3	Limited Correlation between SARS-CoV-2 Serologic Assays for Identification of High-Titer COVID-19 Convalescent Plasma Using FDA Thresholds 2022 ·Microbiology Spectrum ·(unknown), Radwa Ewaisha, (unknown), Matthew M. Roforth, Dane Granger, Calvin R. Jerde, Liang Wu, (unknown), Stephen A. Klassen, Jonathon W. Senefeld, Michael J. Joyner, N Baumann, Elitza S. Theel, John R. Mills	4
4	Identification of Caveolae-Associated Protein 4 Autoantibodies as a Biomarker of Immune-Mediated Rippling Muscle Disease in Adults 2022 ·JAMA Neurology ·Divyanshu Dubey, Grayson Beecher, M Bakri Hammami, Andrew M. Knight, Teerin Liewluck, James Triplett, (unknown), Surendra Dasari, Youwen Zhang, Matthew M. Roforth, Calvin R. Jerde, Stephen J. Murphy, William J. Litchy, Anthony A. Amato, Vanda A. Lennon, Andrew McKeon, John R. Mills, Sean J. Pittock, Margherita Milone	18
5	SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods 2021 ·Journal of Clinical Microbiology ·Elitza S. Theel, Patrick W. Johnson, Katie L. Kunze, Liang Wu, (unknown), Dane Granger, Matthew M. Roforth, Calvin R. Jerde, (unknown), Kylie J. Andersen, (unknown), Julie Harring, Douglas F. Lake, Sergei Svarovsky, Jonathon W. Senefeld, Rickey E. Carter, Michael J. Joyner, N Baumann, John R. Mills	18
6	Targeted Detection of SARS-CoV-2 Nucleocapsid Sequence Variants by Mass Spectrometric Analysis of Tryptic Peptides 2021 ·Journal of Proteome Research ·(unknown), Santosh Renuse, (unknown), Anil K. Madugundu, Patrick M. Vanderboom, Joseph H. Blommel, Calvin R. Jerde, Surendra Dasari, Benjamin R. Kipp, Ravinder J. Singh, Stefan K. Grebe, Akhilesh Pandey	10
7	Gene‐Specific Variant Classifier (DPYD‐Varifier) to Identify Deleterious Alleles of Dihydropyrimidine Dehydrogenase 2018 ·Clinical Pharmacology & Therapeutics ·Shikshya Shrestha, Cheng Zhang, Calvin R. Jerde, (unknown), Hu Li, Steven M. Offer, Robert B. Diasio	52
8	Quantitative Contribution of rs75017182 to Dihydropyrimidine Dehydrogenase mRNA Splicing and Enzyme Activity 2017 ·Clinical Pharmacology & Therapeutics ·(unknown), Shikshya Shrestha, (unknown), (unknown), Kelly J. Bouchonville, (unknown), Rongqian Wu, Calvin R. Jerde, Zhiquan Wang, P Kubica, (unknown), (unknown)	45
9	Histone H3K27 Trimethylation Modulates 5-Fluorouracil Resistance by Inhibiting PU.1 Binding to the DPYD Promoter 2016 ·Cancer Research ·(unknown), (unknown), Erin E. Tapper, Calvin R. Jerde, Garrett S. Dunlap, Shikshya Shrestha, Tarig Elraiyah, Steven M. Offer, Robert B. Diasio	18
10	Glycogen Synthase Kinase 3 (GSK-3)-mediated Phosphorylation of Uracil N-Glycosylase 2 (UNG2) Facilitates the Repair of Floxuridine-induced DNA Lesions and Promotes Cell Survival 2016 ·Journal of Biological Chemistry ·Carly Baehr, Catherine J. Huntoon, (unknown), Calvin R. Jerde, Larry M. Karnitz	15
11	Novel Deleterious Dihydropyrimidine Dehydrogenase Variants May Contribute to 5‐Fluorouracil Sensitivity in an East African Population 2016 ·Clinical Pharmacology & Therapeutics ·Tarig Elraiyah, Calvin R. Jerde, Shikshya Shrestha, Rongmei Wu, (unknown), (unknown), Vivekananda Sarangi, Lewis R. Roberts, (unknown), (unknown)	29
12	microRNAs miR-27a and miR-27b Directly Regulate Liver Dihydropyrimidine Dehydrogenase Expression through Two Conserved Binding Sites 2014 ·Molecular Cancer Therapeutics ·Steven M. Offer, Gabriel L. Butterfield, Calvin R. Jerde, Croix C. Fossum, Natalie J. Wegner, Robert B. Diasio	74
13	TRPC3 regulates release of brain-derived neurotrophic factor from human airway smooth muscle 2013 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Pawan K. Vohra, Michael A. Thompson, Venkatachalem Sathish, Alexander Kiel, Calvin R. Jerde, Christina M. Pabelick, Brij B. Singh, Y. S. Prakash	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact